Title:
CRYSTALLINE OR AMORPHOUS FORM OF STEROID DERIVATIVE FXR AGONIST, PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/020068
Kind Code:
A8
Abstract:
Disclosed are a crystalline or amorphous form of steroid derivative FXR agonist (formula I), and a preparation method therefor, and a crystalline composition and pharmaceutical composition comprising the crystalline or amorphous form, and the use of same in the preparation of a drug for treating or preventing various conditions associated with FXR.
Inventors:
LI XIAOLIN (CN)
XIAO HUALING (CN)
LI PENG (CN)
HE HAIYING (CN)
LI WEIDONG (CN)
XIAO HUALING (CN)
LI PENG (CN)
HE HAIYING (CN)
LI WEIDONG (CN)
Application Number:
PCT/CN2018/097161
Publication Date:
May 02, 2019
Filing Date:
July 26, 2018
Export Citation:
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
MEDSHINE DISCOVERY INC (CN)
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07J43/00; A61K31/58; A61P1/16; A61P3/04; A61P3/06; A61P3/10; A61P9/10; A61P13/02
Attorney, Agent or Firm:
BEIJING SUNHOPE INTELLECTUAL PROPERTY LTD. (CN)
Download PDF:
Previous Patent: METHOD FOR PREPARING STEROID DERIVATIVE FXR AGONIST
Next Patent: SOST ANTIBODY PHARMACEUTICAL COMPOSITION AND USES THEREOF
Next Patent: SOST ANTIBODY PHARMACEUTICAL COMPOSITION AND USES THEREOF